At Photonic Pharma LLC, we focus on the early phase of drug development - Lead Discovery - using a game-changing technology platform that combines breakthroughs in fluorescent biosensor engineering and fluorescence lifetime detection in living cells. Thus we achieve a dramatic increase in the precision of high-throughput screening, with the potential to transform the productivity of pharmaceutical development.
Photonic Pharma works with industrial and academic collaborators, applying its proprietary advancements in structure-based drug-screening technology, to discover novel small-molecule effectors of therapeutically important protein targets. We have assembled a robust and highly integrated network of techniques, concepts, facilities, and collaborators to address a wide range of therapeutic goals.
Photonic Pharma works with industrial and academic collaborators, applying its proprietary advancements in structure-based drug-screening technology, to discover novel small-molecule effectors of therapeutically important protein targets. We have assembled a robust and highly integrated network of techniques, concepts, facilities, and collaborators to address a wide range of therapeutic goals.